Correlation of intellectual impairment in Parkinson's disease with FDG PET scan

No abstract is available for this paper.

• Publication year

  2000

• Venue

  NeuroReport

• Publication date

  2000-07-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00001756-200007140-00016PMID 10923659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography

  2004cited by this paper
• Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

  1999cited by this paper
• Sensitivity to ageing of the limbic dopaminergic system: a review.

  1998cited by this paper
• Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease.

  1996cited by this paper
• Clues about the functional neuroanatomy of verbal working memory: a study of resting brain glucose metabolism in Parkinson's disease

  1995cited by this paper
• Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease

  1995cited by this paper
• Cardiac output determined by the CO2 rebreathing method during arm exercise.

  1994cited by this paper
• Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.

  1992cited by this paper
• Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex.

  1992cited by this paper
• Severity and Specificity of Cognitive Impairment in Alzheimer's, Huntington's, and Parkinson's Diseases and Progressive Supranuclear Palsy

  1991cited by this paper
• Performance evaluation of the PC-2048: a new 15-slice encoded-crystal PET scanner for neurological studies.

  1991cited by this paper
• Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.

  1990cited by this paper
• Cortical glucose metabolism in parkinson's and alzheimer's disease

  1990cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

  1984cited by this paper
• Cortical abnormalities in Alzheimer's disease

  1984cited by this paper
• Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

  1983cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Parkinsonism

  1967cited by this paper

• Nonmotor problems in Parkinson disease

  2021cites this paper
• Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia

  2018cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• Use of PET in Neurology and Psychiatry

  2013cites this paper
• 18F-FDG PET studies in the diagnosis of cognitive impairments associated with Parkinson disease

  2012cites this paper
• PET and MR imaging in Parkinson’s disease patients with cognitive impairment. A study of dopaminergic dysfunction, amyloid deposition, cortical hypometabolism and brain atrophy

  2011cites this paper
• Does the Brain Prefer Geometrical Homogeneity?

  2010cites this paper
• Correlation between Focal Brain Metabolism and Higher Brain Function in Patients with Moyamoya Disease

  2010cites this paper
• Decision Making under Risk Condition in Patients with Parkinson’s Disease: A Behavioural and fMRI Study

  2010cites this paper
• Metabolic alterations in patients with Parkinson disease and visual hallucinations.

  2007cites this paper
• Chapter 8 – Nonmotor Problems in Parkinson Disease

  2007cites this paper
• [11C]d-threo-methylphenidate PET in patients with Parkinson’s disease and essential tremor

  2006cites this paper
• [(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor.

  2006cites this paper
• Positron Emission Tomography and Single-Photon Emission Tomography in the Diagnosis of Parkinson’s Disease

  2005cites this paper
• Positron Emission Tomography and Single-Photon Emission Tomography in the Diagnosis of Parkinson’s Disease Differential Diagnosis From Parkinson-Like Degenerative Diseases

  2005cites this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004cites this paper
• Functional brain imaging in the differential diagnosis of Parkinson's disease.

  2004cites this paper
• [Pathogenetic bases of cognitive and psychotic disorders in Parkinson's disease].

  2004cites this paper
• Positron emission tomography in clinical neurology.

  2004cites this paper
• Progress in Clinical Neurosciences: Parkinson's Disease with Dementia and Dementia with Lewy Bodies

  2004cites this paper
• Substance Misuse

  2001cites this paper